{
    "clinical_study": {
        "@rank": "164740", 
        "arm_group": [
            {
                "arm_group_label": "Low Intensity Shockwave treatment", 
                "arm_group_type": "Experimental", 
                "description": "4 weekly sessions of Low Intensity Shockwave treatment."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Sham Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective, randomized, double-blind clinical study comparing safety and efficacy\n      of the treatments performed with the Low Intensity Extracorporeal Shockwave Therapy\n      (LI-ESWT) device - \"Renova\" on symptomatic ED patients to the safety and efficacy of the\n      control sham patients."
        }, 
        "brief_title": "Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Vasculogenic Erectile Dysfunction", 
        "condition_browse": {
            "mesh_term": "Erectile Dysfunction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Good general health\n\n          -  Vascular ED for at least 6 months\n\n          -  International Index of Erectile Function 6 (IIEF-EF) between 11 to 25\n\n          -  Positive response to PDE5-I (able to penetrate on demand=Responders)\n\n          -  Negative response to PDE5-I (unable to penetrate on demand even with maximum  PDE5-I\n             dosage = Non-responders)\n\n          -  Stable heterosexual relationship for more than 3 months\n\n        Exclusion Criteria:\n\n          -  Hormonal, neurological or psychological pathology\n\n          -  Past radical prostatectomy or extensive pelvic surgery\n\n          -  Recovering from cancer during last 5 years\n\n          -  Any unstable medical, psychiatric, spinal cord injury and penile anatomical\n             abnormalities\n\n          -  Clinically significant chronic hematological disease\n\n          -  Anti-androgens, oral or injectable androgens\n\n          -  Past radiotherapy treatment of the pelvic region\n\n          -  International normalized ratio (INR) > 3 for patients using blood thinners (such as\n             Coumadin)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01811797", 
            "org_study_id": "RENO-03-ICH"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low Intensity Shockwave treatment", 
                "intervention_name": "Low Intensity Shockwave by Renova", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "Sham treatment that looks, sounds and feels like the real LISW treatment.", 
                "intervention_name": "Sham treatment", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Erectile Dysfunction", 
            "Extracorporeal shockwave", 
            "Low intensity shockwaves"
        ], 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tel-Aviv", 
                    "country": "Israel"
                }, 
                "name": "The Tel-Aviv Sourasky Medical Center"
            }, 
            "investigator": {
                "last_name": "Juza Chen, Prof., M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Double Blind With Sham Control, Clinical Study to Assess the Safety and Efficacy Associated With Treating Patients Suffering From Erectile Dysfunction With Low Intensity Shockwaves by Renova", 
        "overall_contact": {
            "email": "juza@tlvmc.gov.il", 
            "last_name": "Juza Chen, Prof., M.D", 
            "phone": "+972-3-6050859"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Israel: Ministry of Health", 
                "Israel: The Israel National Institute for Health Policy Research and Health Services Research"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in the IIEF-EF (International Index of Erectile Function- Erectile Function Domain) score at 3 and 6 months post treatment", 
            "safety_issue": "No", 
            "time_frame": "1, 3 and 6 months post treatment"
        }, 
        "reference": [
            {
                "PMID": "20451317", 
                "citation": "Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010 Aug;58(2):243-8. doi: 10.1016/j.eururo.2010.04.004. Epub 2010 May 6."
            }, 
            {
                "PMID": "22425129", 
                "citation": "Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012 May;187(5):1769-75. doi: 10.1016/j.juro.2011.12.117. Epub 2012 Mar 15."
            }, 
            {
                "PMID": "12152111", 
                "citation": "Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002 Aug;14(4):226-44. Review."
            }, 
            {
                "PMID": "21855209", 
                "citation": "Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011 Nov;60(5):1010-6. doi: 10.1016/j.eururo.2011.07.053. Epub 2011 Jul 30."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01811797"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in the SEP (Sexual Encounter Profile) Questions 2 and 3 at 3 and 6 months post treatment", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post treatment"
            }, 
            {
                "measure": "Change from baseline in the GAQ (Global Assessment Questions)  at 3 and 6 months post treatment", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post treatment"
            }, 
            {
                "measure": "Change from baseline in the EDITS (Erectile Dysfunction Inventory of Treatment Satisfaction) score at 3 and 6 months post treatment", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post treatment"
            }, 
            {
                "measure": "Change from baseline in the Partner EDITS (Erectile Dysfunction Inventory of Treatment Satisfaction) score at 3 and 6 months post treatment", 
                "safety_issue": "No", 
                "time_frame": "1, 3 and 6 months post treatment"
            }, 
            {
                "measure": "Change from baseline in the IPSS (International Prostate Symptom Score) at the end of the treatment", 
                "safety_issue": "No", 
                "time_frame": "0 and 6 months post treatment"
            }
        ], 
        "source": "Initia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Initia", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}